[HTML] frontiersin.org

[HTML][HTML] Cost-effectiveness of direct oral anticoagulant vs. warfarin among atrial fibrillation patients with intermediate stroke risk

JH Choi, W Kim, YT Kim, J Cho, SY Shin… - Frontiers in …, 2022 - frontiersin.org
Background: Several studies have shown the cost-effectiveness of direct oral anticoagulants
(DOACs), compared with warfarin, to prevent atrial fibrillation (AF) related complications …
被引用次数：5 相关文章

Cost-effectiveness of Direct Oral Anticoagulant vs. Warfarin Among Atrial Fibrillation Patients With Intermediate Stroke Risk.

JH Choi, W Kim, YT Kim, J Cho, SY Shin… - Frontiers in …, 2022 - europepmc.org
Background Several studies have shown the cost-effectiveness of direct oral anticoagulants
(DOACs), compared with warfarin, to prevent atrial fibrillation (AF) related complications …

[引用][C] Cost-effectiveness of Direct Oral Anticoagulant vs. Warfarin Among Atrial Fibrillation Patients With Intermediate Stroke Risk

JH Choi, W Kim, YT Kim, J Cho, SY Shin… - Frontiers in …, 2022 - jglobal.jst.go.jp
Cost-effectiveness of Direct Oral Anticoagulant vs. Warfarin Among Atrial Fibrillation
Patients With Intermediate Stroke Risk | Article Information | J-GLOBAL Art J-GLOBAL ID:202202220694417206 …

Cost-effectiveness of Direct Oral Anticoagulant vs. Warfarin Among Atrial Fibrillation Patients With Intermediate Stroke Risk

JH Choi, W Kim, YT Kim, J Cho… - Frontiers in …, 2022 - pubmed.ncbi.nlm.nih.gov
Background Several studies have shown the cost-effectiveness of direct oral anticoagulants
(DOACs), compared with warfarin, to prevent atrial fibrillation (AF) related complications …

Cost-effectiveness of Direct Oral Anticoagulant vs. Warfarin Among Atrial Fibrillation Patients With Intermediate Stroke Risk

JH Choi, W Kim, YT Kim, J Cho… - Frontiers in …, 2022 - khu.elsevierpure.com
Background: Several studies have shown the cost-effectiveness of direct oral anticoagulants
(DOACs), compared with warfarin, to prevent atrial fibrillation (AF) related complications …

Cost-effectiveness of Direct Oral Anticoagulant vs. Warfarin Among Atrial Fibrillation Patients With Intermediate Stroke Risk

JH Choi, W Kim, YT Kim, J Cho, SY Shin, C Kim… - 2022 - ir.ymlib.yonsei.ac.kr
Background: Several studies have shown the cost-effectiveness of direct oral anticoagulants
(DOACs), compared with warfarin, to prevent atrial fibrillation (AF) related complications …

Cost-effectiveness of Direct Oral Anticoagulant vs. Warfarin Among Atrial Fibrillation Patients With Intermediate Stroke Risk

JH Choi, W Kim, YT Kim, J Cho… - FRONTIERS IN …, 2022 - scholarworks.bwise.kr
BackgroundSeveral studies have shown the cost-effectiveness of direct oral anticoagulants
(DOACs), compared with warfarin, to prevent atrial fibrillation (AF) related complications …

Cost-effectiveness of Direct Oral Anticoagulant vs. Warfarin Among Atrial Fibrillation Patients With Intermediate Stroke Risk

JH Choi, W Kim, YT Kim, J Cho… - Frontiers in …, 2022 - yonsei.elsevierpure.com
Background: Several studies have shown the cost-effectiveness of direct oral anticoagulants
(DOACs), compared with warfarin, to prevent atrial fibrillation (AF) related complications …
[HTML] nih.gov

[HTML][HTML] Cost-effectiveness of Direct Oral Anticoagulant vs. Warfarin Among Atrial Fibrillation Patients With Intermediate Stroke Risk

JH Choi, W Kim, YT Kim, J Cho, SY Shin… - Frontiers in …, 2022 - ncbi.nlm.nih.gov
Background Several studies have shown the cost-effectiveness of direct oral anticoagulants
(DOACs), compared with warfarin, to prevent atrial fibrillation (AF) related complications …